Drug recall · October 10, 2012
Famotidine Tablets USP recall
Why: Impurities/Degradation Products: Out of specification results for Related Compound during routine stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Famotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-3020-01
- Lots / codes
Lot: 3018952, Exp 08/12
- Quantity
- 31,867 Bottles
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Nationwide and PR
- Initiated
- June 28, 2012 · Voluntary: Firm initiated
- Classified
- September 28, 2012
- Reported
- October 10, 2012
- Ended
- March 29, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Famotidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.